How Compatible Are Immune Checkpoint Inhibitors and Thermal Ablation for Liver Metastases?

SIMPLE SUMMARY: Although immune checkpoint inhibitors (ICIs) have achieved great progression in cancer treatment, the efficacy of ICI monotherapy is still limited. Meanwhile, the negative efficacy of thermal ablation for liver metastases is the high rate of local tumor progression. Since thermal abl...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Yasunori, Takaki, Haruyuki, Yamakado, Koichiro, Kudo, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103121/
https://www.ncbi.nlm.nih.gov/pubmed/35565338
http://dx.doi.org/10.3390/cancers14092206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103121/
https://www.ncbi.nlm.nih.gov/pubmed/35565338
http://dx.doi.org/10.3390/cancers14092206

Ejemplares similares